Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
ConditionEpilepsies, Partial
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorOno Pharmaceutical Co., Ltd.
About this trial
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Eligibility criteria
Qualifiers
Subjects completed Study YKP3089C035 by SK Life Science.
Disqualifiers
Subjects that have previously discontinued for any reason from the Core study (YKP3089C035).
Any significant changes to the medical history of the subject that in the opinion of the investigator, could affect the safety of the subject.
Trial design
Treatments tested in this trial
- Cenobamate
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov